Neu5gc-lewis a-targeting molecules and uses thereof in cancer

Abstract

The disclosure relates to the discovery of Neu5Gc-Lewisa as a biomarker for cancer cells and tissues and provides methods for diagnosis, treatment, and drug targeting based on the same, as well as molecules that specifically bind to Neu5Gc-Lewisa.

Dependencies are inferred from the claim text.